This population-based cohort study disaggregates mortality data from the National Center for Health Statistics for different types of cardiovascular disease among the 3 largest US Hispanic subgroups, Mexicans, Puerto Ricans, and Cubans.
This cohort study uses data from the National Inpatient Sample database to examine rates of in-hospital reperfusion and outcomes among renal transplant recipients hospitalized with ST-segment elevation myocardial infarction.
This longitudinal study characterizes myocardial infarctions, including type, identifies causes of type 2 myocardial infarctions, and compares demographic and clinical characteristics among human immunodeficiency virus–infected individuals with type 1 vs type 2 myocardial infarctions.
This secondary analysis of a randomized clinical trial evaluates the 5-year outcomes of zotarolimus-eluting stents vs everolimus-eluting stents to treat randomized participants and nonenrolled eligible patients with non–ST-segment elevation acute coronary syndromes.
This case-control study evaluates whether an imbalance of cardiac autonomic tone and increased systemic oxidative stress and inflammation are detectable in otherwise healthy humans who habitually use e-cigarettes.
This study investigates the association between bicuspid aortic valve morphologic findings (raphe vs nonraphe) and the degree of valve dysfunction, presence of aortopathy, and prognosis (including need for aortic valve surgery, aortic dissection, and all-cause mortality).
This cohort study assesses the structural and electrical progression of arrhythmogenic right ventricular dysplasia/cardiomyopathy in patients over time.
This case-matched cohort study examines whether serum retinol-binding protein 4, an endogenous transthyretin ligand, is a valid diagnostic test for transthyretin cardiac amyloidosis among African Americans with heart failure.
This analysis of 3 community-based cohort studies determines absolute rates and risk differences of incident heart failure, coronary heart disease, and stroke in participants with vs without chronic kidney disease.
This study describes the evidence base and changes in recommendations from 2001 to 2014 in the American Heart Association/American College of Cardiology/Heart Rhythm Society guidelines on management of atrial fibrillation.
This review assesses the benefits of cardiovascular implantable electronic devices for the detection and treatment of subclinical atrial fibrillation among patients enrolled in clinical studies.
A woman in her late 50s with a history of multiple sclerosis, without traditional atherosclerosis risk factors and not taking medications, presented to the emergency department after having 30 minutes of pain in her left shoulder and vague chest pressure that had already resolved. What would you do next?
This clinical evidence synopsis evaluates 22 randomized clinical trials in 14 countries to determine if concomitant atrial fibrillation surgery is effective at reducing atrial fibrillation, atrial flutter, and atrial tachycardia among patients undergoing cardiac surgery.
This guideline presents recommendations for managing supraventricular tachycardia.
This study uses National Health and Nutrition Examination Survey data to determine trends in mean total cholesterol, triglycerides, and low-density lipoprotein levels in the United States.
This study finds that most patients undergoing warfarin therapy for atrial fibrillation discontinue it within the first year, particularly those who have scheduled electrical cardioversion or radiofrequency ablation.